Five Prime Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2020 to a ratio of 8.87, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2020. Average receivable collection period, for the Five Prime Therapeutics Inc in Dec 31 2020 quarter, has decreased to 41 days, compared to 53 days, in the Sep 30 2020 quarter.

If we take a look into Healthcare sector 574 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2020 from 3653 to 4075.

What is Receivable Turnover Ratio?
What is Five Prime Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FPRX Receivables Turnover Ratio	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Receivable Change	-97.93 %	-59.53 %	-14.99 %	-35.59 %	-19.6 %
Y / Y Revenue Change	-	-31.37 %	2.73 %	57.36 %	-2.07 %
Receivable Turnover Ratio (TTM)	8.87	6.87	5.94	5.73	4.33
FPRX's Total Ranking	# 4075	# 3653	# 1422	# 3656	# 1445
Accounts Receivable average collection period days	41	53	61	64	84
Seq. Receivable Change	-94.27 %	-32.96 %	2.12 %	-47.13 %	11.82 %
Seq. Revenue Change	-	-40.19 %	-59.31 %	162.12 %	7.57 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 222
Healthcare Sector	# 575
Overall Market	# 4075

Receivable Turnover Ratio Statistics
High	Average	Low
1.28	0.23	0.05
(Dec 31 2015)		(Sep 30 2019)

FPRX Company Profile • Back to FPRX Efficiency Comparisons • Compare FPRX Receivables Turnover Ratio to its Competitors

Financial Statements
Five Prime Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit FPRX's Balance sheet
Five Prime Therapeutics Inc 's Sales TTM	$ 13 Millions	Visit FPRX's Income Statement
Sources of FPRX's Revenues		Visit FPRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FPRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FPRX's Growth Rates	FPRX's Roa	FPRX's Inventory Turnover Ratio	FPRX's Dividend Comparisons
FPRX's Profitability Ratios	FPRX's Roi	FPRX's Asset Turnover Ratio	FPRX's Dividend Growth
FPRX's Valuation Ratios	FPRX's Roe	FPRX's Financial Strength Ratios	FPRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2020	Receivable at quarter ending Dec 31 2020
Bioadaptives Inc	364.85	$ 0.016 Millions	$ 0.000 Millions
Arcus Biosciences Inc	246.09	$ 77.517 Millions	$ 0.315 Millions
Aurinia Pharmaceuticals Inc	245.60	$ 138.030 Millions	$ 0.562 Millions
Denali Therapeutics Inc	236.63	$ 335.659 Millions	$ 1.419 Millions
Iqvia Holdings Inc	192.53	$ 11,359.000 Millions	$ 59.000 Millions
Logicmark Inc	191.75	$ 11.443 Millions	$ 0.060 Millions
Waters Corporation	179.95	$ 2,365.365 Millions	$ 13.144 Millions
Bausch Health Companies Inc	167.23	$ 8,027.000 Millions	$ 48.000 Millions
Vystar Corporation	157.96	$ 20.979 Millions	$ 0.133 Millions
H cyte Inc	151.33	$ 2.151 Millions	$ 0.014 Millions
Sunshine Biopharma Inc	149.08	$ 0.071 Millions	$ 0.000 Millions
Affimed N v	115.28	$ 31.763 Millions	$ 0.276 Millions
Endonovo Therapeutics Inc	113.07	$ 0.166 Millions	$ 0.001 Millions
Acura Pharmaceuticals inc	105.00	$ 3.570 Millions	$ 0.034 Millions
Grapefruit Usa Inc	96.06	$ 3.672 Millions	$ 0.038 Millions
Kindred Biosciences Inc	90.19	$ 42.164 Millions	$ 0.467 Millions
Lifemd Inc	83.75	$ 37.294 Millions	$ 0.445 Millions
Lifevantage Corp	81.83	$ 229.279 Millions	$ 2.802 Millions
Zeo Scientifix Inc	76.69	$ 3.727 Millions	$ 0.049 Millions
Guardion Health Sciences Inc	76.08	$ 1.890 Millions	$ 0.025 Millions
Tvardi Therapeutics Inc	75.37	$ 135.082 Millions	$ 1.792 Millions
Medicure Inc	74.42	$ 8.893 Millions	$ 0.119 Millions
Immunogen inc	73.23	$ 132.299 Millions	$ 1.807 Millions
Orthofix Medical Inc	72.84	$ 406.562 Millions	$ 5.582 Millions
Creative Medical Technology Holdings Inc	67.14	$ 0.165 Millions	$ 0.002 Millions
Blueprint Medicines Corporation	53.91	$ 800.334 Millions	$ 14.845 Millions
Wearable Health Solutions, Inc.	52.81	$ 1.285 Millions	$ 0.024 Millions
Nature s Sunshine Products inc	52.59	$ 385.205 Millions	$ 7.325 Millions
Sonida Senior Living Inc	47.90	$ 383.864 Millions	$ 8.014 Millions
Healthlynked Corp	47.81	$ 6.133 Millions	$ 0.128 Millions

Date modified: 2026-06-22T14:32:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.